Helen Torley sold $6.4M of HALO stock

Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 60,000 shares of HALO stock worth $6.4M, per an SEC Form 4 filed Sep 12, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 9, 2026, 3 days before it was made public.

HALO has moved -6.3% since the trade date, from $107.39 to $100.67 (Nov 12, 2026 close).